
Inappropriate production of the iron-regulatory hormone hepcidin contributes to the pathogenesis of common iron disorders. Absolute or relative deficiency of hepcidin causes iron overload in hereditary hemochromatosis and iron-loading anemias. Elevated hepcidin causes iron restriction in inflammatory conditions including autoimmune disease, critical illness, some cancers, and chronic kidney disease. Multiple agents targeting hepcidin and its regulators are under development as novel therapeutics for iron disorders. This review summarizes hepcidin biology and discusses the current landscape for hepcidin-targeting therapeutic strategies.
Iron Overload, Liver Disease, Iron, Anemia, Hematology, Biological Sciences, anemia, Medical and Health Sciences, Hepcidins, 2.1 Biological and endogenous factors, Animals, Humans, Pharmacology & Pharmacy, Aetiology, iron disorders, iron overload, Digestive Diseases, ferroportin
Iron Overload, Liver Disease, Iron, Anemia, Hematology, Biological Sciences, anemia, Medical and Health Sciences, Hepcidins, 2.1 Biological and endogenous factors, Animals, Humans, Pharmacology & Pharmacy, Aetiology, iron disorders, iron overload, Digestive Diseases, ferroportin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 126 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
